多发性骨髓瘤基因组演化视角
本综述探讨基因组演化、环境与遗传易感性及免疫监视在从前驱状态(冒烟型多发性骨髓瘤和意义未明的单克隆丙种球蛋白病)向多发性骨髓瘤进展中的复杂交互作用。遗传易感性在初始转化中起重要作用,早期基因组事件如易位和超二倍体是前驱起始的关键,但通常需要额外因素如亚克隆群的阳性选择才能转化为症状性疾病,该过程受衰老和环境因素影响。整合基因组和转录组数据与免疫分析或其他临床特征对于识别高进展风险患者至关重要。
要点
- 多发性骨髓瘤普遍由前驱状态(MGUS和SMM)先行发生,常早于诊断数十年。
- 早期基因组事件(易位、超二倍体)是前驱起始的关键,但转化需亚克隆阳性选择等额外因素。
- 整合基因组、转录组与免疫分析有助于识别高进展风险患者。
核心结论
- 骨髓瘤发生是基因组演化、环境与遗传易感性及免疫监视复杂交互的结果,需先进方法改进疾病预测。
研究设计与样本
- 综述,探讨基因组演化、环境与遗传易感性及免疫监视在从前驱状态向多发性骨髓瘤进展中的作用。
主要发现
- 多发性骨髓瘤普遍由前驱状态先行发生,常早于诊断数十年。
- 遗传易感性由种系变异和MM特异性位点驱动,在初始转化中起重要作用。
- 前驱状态和MM发生率在种族群体间的差异凸显易感性的作用及更广泛队列研究的必要性。
- 早期基因组事件如易位和超二倍体是前驱起始的关键。
- 转化为症状性疾病通常需要额外因素如亚克隆群的阳性选择,受衰老和环境因素(如橙剂和农用化学品暴露)影响。
临床怎么用
- 整合基因组和转录组数据与免疫分析或其他临床特征,以识别高进展风险的多发性骨髓瘤患者。
局限性
- 需更广泛的队列研究以阐明种族差异背后的易感性因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this review, we explore the role of complex interactions between genomic evolution, environmental and genetic predispositions, and immune surveillance in disease progression from precursor conditions smoldering multiple myeloma and monoclonal gammopathy of undetermined significance to multiple myeloma (MM). MM has been described to be universally preceded by precursor states, often decades before it is even diagnosed. Genetic predisposition plays an important role in the initial transformation, and is driven by both germline variants and MM-specific loci influencing risk. The reported disparities in occurrence of precursor conditions and MM among racial groups highlights the role of predisposition and the need for broader cohort studies. Early genomic events, such as translocations and hyperdiploidy, are essential in precursor initiation. However, additional factors are usually needed to transform the precursor stages into symptomatic disease, such as positive selection of subclonal populations. This process is affected by aging and environmental factors, such as exposures to Agent Orange and agrochemicals. Therefore, integrating genomic and transcriptomic data with immune profiling or other clinical features is essential for identifying patients with high risk of progressing into MM. Here, we highlight the complexity of myelomagenesis, and underline the importance of state-of-the-art approaches for improved disease prediction.
引用
- Maura F, Samur M, Munshi N, et al. Evolution of multiple myeloma from a genomic perspective. Blood. 2026. PMID: 41359792. doi:10.1182/blood.2024026313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。